Search results
Results from the WOW.Com Content Network
PVP-I is approved for treatment of bacterial vaginosis as a vaginal gel. [18] [19] [20] Brand names include Astodrimer Sodium or Astrodimer 1% Vaginal Gel, Betadine BV, Betafem BV, Viraleze, and VivaGel, among others. [18] [19] [20] Vaginal suppositories are also available and used. [21]
Results released in February 2009 from a clinical trial of PRO 2000 (Indevus Pharmaceuticals), a vaginal-microbicide gel (0.5%), sparked hope that it might provide modest protection against HIV. [22] The results of a larger trial released in December 2009 showed that PRO 2000 was safe as administered, but was ineffective in reducing the risk of ...
The Krazy Koupon Lady compared the prices of diapers at Target and Walmart and Target won by a longshot. Several comparisons included: Pampers Cruisers Size 3, 140 count: Target: $44.99. Walmart ...
The trial involved 222 men, ages 18 to 50, who applied 5 milliliters of the gel (about a teaspoon) to each of their shoulder blades once per day. The second part of the two-part trial is still ...
Administering a vaginal tablet without an applicator. Intravaginal administration is a route of administration where the substance is applied inside the vagina . Pharmacologically , it has the potential advantage to result in effects primarily in the vagina or nearby structures (such as the vaginal portion of cervix ) with limited systemic ...
Target gave the following examples of items that will see cuts: Crisco Vegetable Oil (40 fl. oz) now $4.79 (down from $5.29) Coffee Mate Natural Bliss Sweet Cream Creamer (32 fl. oz) now $4.99 ...
NES/T (Nesterone/Testosterone gel) is a transdermal gel that users apply to the upper arms and shoulders once daily. [ 77 ] [ 78 ] Developed as a collaboration between the NICHD and Population Council , NES/T is in a phase II clinical trial, [ 79 ] where it is being evaluated for safety and efficacy, with healthy couples relying on it as their ...
Nonoxynol-9 is a common ingredient of most vaginal and anal lubricants due to its spermicidal properties. A 2004 study found that over a six-month period, the typical-use failure rates for five nonoxynol-9 vaginal contraceptives (film, suppository, and gels at three different concentrations) ranged from 10% to 20%.